P-Cure Ltd

P-Cure Ltd is a medical technology company founded in 2007, focused on developing compact, gantry-less proton therapy systems for cancer treatment. The company aims to make proton therapy more accessible by providing FDA-cleared solutions that allow for treatment in both seated and supine positions, enhancing patient comfort and treatment accuracy. Headquartered in Israel, with a U.S. office in Akron, Ohio, P-Cure collaborates with major medical equipment providers to expand its technological reach. Its flagship product, the P-Cure Proton Beam Therapy System, is a synchrotron-based accelerator that delivers precise pencil beam scanning proton therapy. This system is significantly smaller than traditional setups, requiring less shielding and reducing capital costs, which facilitates wider availability for cancer treatment centers. P-Cure also offers installation and support services for its systems, integrating them with imaging and treatment planning technologies. Their solutions are designed for cancer treatment centers and hospitals looking to improve treatment precision while minimizing operational costs.

• Employees 43
• Founded 2007
• Annual Revenue $4884000
• Total Funding $25000000